PT - JOURNAL ARTICLE AU - Muharram, Farizal Rizky AU - Andrianto, Andrianto AU - Salsabilla, Senitza Anisa AU - Multazam, Chaq El Chaq Zamzam AU - Harmadha, Wigaviola Socha AU - Dakota, Iwan AU - Andriantoro, Hananto AU - Firman, Doni AU - Prakoso, Radityo TI - Catheter Laboratory Facilities in Indonesia: Number, Growth, and Distribution in The Largest Archipelago Nation AID - 10.1101/2023.04.14.23288607 DP - 2023 Jan 01 TA - medRxiv PG - 2023.04.14.23288607 4099 - http://medrxiv.org/content/early/2023/04/19/2023.04.14.23288607.short 4100 - http://medrxiv.org/content/early/2023/04/19/2023.04.14.23288607.full AB - Background Indonesia, the world’s largest archipelago and fourth most populous nation, has limited transportation due to geographical obstacles. This affects the provision of acute time-dependent therapy such as Percutaneous Coronary Intervention (PCI). Indonesia’s ageing population, which will increase Acute Coronary Syndrome prevalence in the next decade, will worsen this problem. Therefore, the analysis and enhancement of cardiovascular care are crucial. The catheterization laboratory (cath lab) performs PCI procedures. This study maps the number and distribution of Indonesia’s cath lab facilities.Methods A direct survey was used to collect the cath lab location data. Population data came from the Ministry of Home Affairs. The growth of cath labs is shown and analyzed by region. The ratio and the Gini index are the primary comparison tools between regions and over time.Findings The number of cath labs in Indonesia significantly increased from 181 to 310 in the last five years, with 44 of the 119 new labs built in an area that did not have one. Java has the most cath labs (208, 67%). The cath lab ratio in the provinces of Indonesia ranges from 0·0 in West Papua and Maluku to 4·46 in Jakarta; the median is 1·09. (IQR 0·71–1·18). The distribution remains a problem, as shown by the high cath lab Gini index (0·48).Interpretation The number of cath labs in Indonesia has increased significantly recently. However, maldistribution remains a concern. In order to improve Indonesia’s cardiovascular emergency services, Future cath lab development must be planned better by considering the facility accessibility and density.Funding The study was conducted with the researcher’s fundsEvidence Before Study Indonesia is the fourth-largest nation by population and the largest archipelagic country. Unfortunately, the number of cath lab facilities nationwide in Indonesia was never examined or mentioned in any previous scientific articles that we could find. According to earlier studies, cathlab accessibility is critical in reducing the time ACS patients take to receive care. It is become crucial to map cathlab locations and plan them in strategic locations.What this Study AddsThis study provides data on the number of cathlabs, their primary geographic distribution, their cath lab-to-population ratio, and their evolution over the previous five years in Indonesia.Our research demonstrates that to ensure equity access, Indonesia, as the largest archipelagic nation, needs government policies that initiate the distribution of cathlabs and the strategic placing of cathlabs as critical factors.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paperAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData are available by requesting an application through email to the corresponding author.